Meta Ads Healthcare Policy Restrictions in India: 2026 Guide

TL;DR

• Meta does not ban healthcare advertising in India, but five overlapping policies (prohibited content, restricted content, personal health attributes, community standards, and country-specific rules) block roughly 1 in 4 healthcare accounts inside the first 30 days.
• Special Ad Categories don't apply to healthcare in India the way they do in the US. What does apply: Meta's Restricted Content rules, the NMC Professional Conduct Regulations, and the DPDP Act 2023.
• An ICG audit of 80+ Indian clinic Meta accounts found three creative patterns cause 70% of rejections. Before-and-after imagery, outcome guarantees, and personal-attribute copy addressing the viewer's condition.
• Landing page compliance decides more Meta review outcomes than creative alone. Doctor credentials, clinic registration, DPDP-aligned privacy policy, and no exaggerated claims are the minimum bar.

Table of contents

• Why this matters for Indian healthcare marketers
• What does Meta consider "restricted" for healthcare in India?
• Do healthcare ads in India need Special Ad Categories?
• What are "personal health attributes" and why do they get ads rejected?
• Can Indian pharma brands run Meta Ads to consumers?
• Which creatives get rejected most often for Indian clinics?
• What does a compliant Indian healthcare landing page look like for Meta Ads?
• How do NMC and DPDP Act rules stack on top of Meta's policy?
• How do you appeal a Meta Ads healthcare rejection in India?
• How does ICG structure Meta Ads for healthcare compliance?
• FAQs

Why this matters for Indian healthcare marketers

Meta is the biggest paid social channel in Indian healthcare, full stop. Instagram alone drives more first-touch enquiries for aesthetics, dental, IVF, and elective ortho than any paid channel outside branded Google search. Ask any hospital marketing director in Mumbai or Bengaluru where their bottom-of-funnel Reels leads come from, and the answer is almost always Meta.

But healthcare is the single most policy-heavy vertical inside Meta's ad review system. The platform treats it as a "sensitive category" globally, which means every ad goes through a stricter classifier, every landing page gets crawled more aggressively, and every rejection lands in your account without much explanation.

For an Indian marketing lead, this shows up in three painful ways. Ads get disapproved in bulk after weeks of production. The ad account gets restricted right when Q3 season kicks in. And the best-performing creative, the one your team spent two weeks planning around a real patient story, never makes it live because Meta's review model flagged personal attribute copy.

Then there is the local layer. Indian healthcare advertising sits under the NMC Professional Conduct Regulations (which tightened again in 2022-23), the ASCI code, the Drugs and Magic Remedies (Objectionable Advertisements) Act, and now the DPDP Act 2023 for anything touching identifiable patient data. Meta's policy is the ceiling. Indian statute is the floor. Most rejected creatives break both at the same time.

What does Meta consider "restricted" for healthcare in India?

Direct answer: Meta restricts, not bans, healthcare advertising through five overlapping policies. Prohibited content, restricted content, personal health attributes, community standards, and country-specific rules. For Indian advertisers, "restricted content" is the layer that catches most clinics off guard because the rules feel invisible until an ad fails review.

Prohibited content will never run. Prescription drug promotion to consumers, unsafe supplements, and content that guarantees medical outcomes all sit here. Restricted content can run, but only if the ad, the landing page, and sometimes the advertiser identity meet extra conditions.

The restricted categories that matter for Indian healthcare cover:

• Cosmetic and aesthetic procedures. Botox, fillers, hair transplant, weight loss surgery, laser treatments
• Weight-loss products and programmes
• Dietary supplements and health-related consumer products
• Sensitive services. Mental health, fertility, sexual wellness, addiction recovery
• Medical devices that require professional oversight

Add the "personal health attributes" rule on top, which changes how you write ad copy for every one of these categories, not just what you sell.

Do healthcare ads in India need Special Ad Categories?

Direct answer: No. Meta's Special Ad Categories (Housing, Employment, Credit, Social Issues) don't apply to healthcare in India today. But that doesn't mean healthcare targeting is unrestricted. It sits under Restricted Content, which behaves much like a Special Ad Category in practice with its own targeting limits and audience shape.

In real campaigns, that means you cannot target based on health interests the same way you can target based on "cricket" or "Bollywood". Meta's ad targeting for anything that suggests disease, condition, or vulnerability is either unavailable or throttled. If you build an audience around "PCOS", "hair loss", or "infertility", you are likely getting broader lookalike behaviour instead of the tight targeting your media plan called for.

For a Gurugram IVF chain we work with, the shift from interest-based targeting to a broad-plus-signal targeting model (age band, geo, ARPU proxy through pincode, creative-driven qualification at the ad level) lifted qualified appointments by roughly 40% within eight weeks. Meta's algorithm was already ignoring the interest signals silently. Once we stopped fighting it, performance opened up.

What are "personal health attributes" and why do they get ads rejected?

Direct answer: "Personal health attributes" is Meta's rule that blocks ads asserting or implying the viewer has a specific medical condition, disability, or health status. Copy like "Struggling with PCOS?" or "Diabetic? Get your sugar under control" reads harmless to a marketer and gets rejected on sight by Meta's review model.

The reason is Meta's Community Standards treat health as a protected personal attribute. Even a soft implication, where the ad addresses the viewer as if you already know their condition, trips the classifier. The rule also protects mental health status, HIV, cancer, physical disability, and pregnancy.

The workaround Indian clinics actually use is inclusive framing. "PCOS treatment in Bengaluru, book a fertility consult" runs cleanly. "You have PCOS, book a fertility consult" doesn't. The first talks about the service. The second identifies the viewer.

Three quick rewrites that pass Indian ad review:

• "Losing hair?" becomes "Hair restoration in Hyderabad, doctor-led"
• "Diabetic and worried about your eyes?" becomes "Diabetic retinopathy screening at our Chennai clinic"
• "Suffering from depression?" becomes "Mental health support and counselling in Mumbai"

Can Indian pharma brands run Meta Ads to consumers?

Direct answer: No, not for prescription products. Meta prohibits prescription drug promotion to consumers globally, and India's Drugs and Magic Remedies (Objectionable Advertisements) Act adds a second layer of prohibition. Indian pharma brand teams can still use Meta, but only for corporate branding, unbranded disease awareness, HCP engagement via B2B lookalikes, and API or CDMO trade audiences.

The compliant playbook for Indian pharma on Meta looks like this:

• Corporate brand campaigns. No product, no claims. Only company story and CSR
• Unbranded disease awareness. Describe the condition, direct to a doctor consult, never name a molecule
• HCP-only targeting through professional audiences. Thought leadership and RX generation
• OTC brand awareness. Only for approved OTC categories with pre-cleared claims

Pharma marketers who try to slip prescription-adjacent content past Meta review typically see the entire ad account restricted within 4-6 weeks. Better to build the compliance playbook first, then scale spend behind it.

Which creatives get rejected most often for Indian clinics?

Direct answer: Three creative patterns cause roughly 70% of rejections in Indian healthcare Meta accounts. Before-and-after imagery, outcome guarantees, and personal-attribute copy addressing the viewer's condition. All three are fixable at the guidelines level, but most clinics fix them one ad at a time.

An ICG audit of 80+ live Indian healthcare Meta accounts (aesthetic clinics in Mumbai, dental chains in Bengaluru, IVF centres in Delhi-NCR, dermatology practices in Hyderabad, multispecialty hospitals in Chennai) showed the breakdown:

Before-and-after images are the biggest single killer. Meta reads them as implying guaranteed outcomes even when the visual is genuine and the disclaimer is present. For Indian clinics, the safer creative build uses process imagery, treatment room shots, doctor-on-camera Reels, patient testimonial voiceovers (audio only, no face), and clinical infographics. Not glamour transformations.

What does a compliant Indian healthcare landing page look like for Meta Ads?

Direct answer: A compliant landing page for Indian healthcare Meta Ads carries visible doctor credentials, clinic registration number, a real physical address, a privacy policy that references the DPDP Act 2023, no exaggerated claims, and a consent mechanism for any lead form. Meta reviews landing pages algorithmically. A policy violation on the page will disable the ad even when the creative is clean.

The minimum landing page bar for Indian healthcare Meta Ads:

• Doctor name, qualification, and NMC registration number visible on page
• Clinic name, address, and Clinical Establishments Act registration where applicable
• Privacy policy that names DPDP Act 2023 and specifies consent, storage, and grievance officer
• Consent checkbox on the lead form (not pre-checked) with clear language on how the data will be used
• No language like "cure", "guaranteed", "100% results", "risk-free", or "best in India"
• Real testimonials only if permitted by NMC. For individual doctors, generally avoid patient testimonials
• SSL enabled, page loads under 3 seconds on 4G, mobile-friendly by default

A Chennai dermatology group we audited had a 61% Meta ad rejection rate driven entirely by landing page violations. The page carried a "guaranteed results" banner that leaked into every campaign's review outcome. Fixing the page fixed over 100 disapproved ads without touching a single ad creative.

How do NMC and DPDP Act rules stack on top of Meta's policy?

Direct answer: NMC's Professional Conduct Regulations restrict what individual doctors can advertise (no self-promotion beyond permitted disclosures, no comparative claims, no soliciting of patient testimonials). DPDP Act 2023 governs how you collect, store, and process health data from lead forms and landing pages. Meta's policy sits on top. An ad can be Meta-compliant and still violate NMC or DPDP.

For clinic owners running personal ads under their doctor identity, NMC is the tighter constraint. Doctors can share qualifications, specialties, clinic timings, and educational content. They cannot use superlatives, patient success stories, comparative claims, or content that could be read as soliciting patients away from another practitioner.

DPDP Act 2023 hits every Meta lead form and every landing page collecting patient enquiries. The three things most clinics still haven't fixed:

• A named data protection or grievance officer on the privacy policy
• Purpose limitation. You can only use the data for what the consent covers
• Retention periods clearly stated, plus a mechanism for the person to request deletion

The practical reading. If your Meta Ads compliance stack does not include an NMC review and a DPDP-aligned lead flow, you are one complaint away from a much bigger problem than an ad disapproval.

How do you appeal a Meta Ads healthcare rejection in India?

Direct answer: Appeal from Ads Manager within 30 days of the rejection notification. In the appeal, cite the specific Meta policy clause your ad meets, describe what the landing page shows, and reference doctor credentials where medical claims are involved. First-appeal success rate for Indian healthcare accounts sits around 30-45%. Higher when the appeal cites specific policy language.

A structured appeal template that works for Indian clinics:

• Line 1. Which policy Meta flagged and why we believe the ad complies
• Line 2. What the landing page carries (credentials, registration, DPDP notice)
• Line 3. How the copy avoids personal-attribute framing or outcome guarantees
• Line 4. A request for human review, not automated re-review

Repeated rejections on the same account create a trust score penalty. Meta's review classifier gets stricter with accounts that generate multiple violations. That is why fixing the guidelines layer (creative rules, landing page template, copywriter briefs) is worth 5x more than fixing individual rejected ads.

How does ICG structure Meta Ads for healthcare compliance?

Direct answer: ICG runs healthcare Meta Ads through a four-layer stack. Creative guardrails baked into every brief, landing page templates pre-audited for DPDP and NMC, competitor intel that shows what actually survives review, and Meta Catalyst IQ for the media buy itself. The compliance work sits upstream of the media buy, not after it.

The four layers in practice:

• Creative guardrails. Copywriter briefs include the personal-attribute rewrite table, banned phrase list, and India-specific claim boundaries. Nothing goes to shoot without passing this brief.
• Landing page templates. Every clinic gets a DPDP-aligned template with placeholder credentials, structured schema, and pre-approved trust markers. Legal review happens once, not per campaign.
• Competitor intel via Prism Spy. ICG's competitor Meta Ads intelligence tool surfaces what other Indian healthcare brands are running (ad copy, creative angles, offer structures). If similar clinics are running specific angles for months, those angles pass review.
• Meta Catalyst IQ. ICG's Meta media engine handles the buy layer. Audience structure, bidding, creative rotation, and lead quality scoring. Compliance is a pre-condition, not a feature.

Alongside Meta, ICG's Instagram analytics tool Prism Pulse tracks whether the compliant creative is actually earning organic pull. A Meta ad that runs but earns no organic engagement is a signal problem, not a policy problem. Nexus CRM (ICG's Rs 14,999/month healthcare CRM) then closes the loop on lead qualification, so what looks like a compliance issue on Meta can be traced back to lead quality data in one system.

ICG's 70-30 pricing model for healthcare Meta Ads

ICG runs healthcare Meta Ads under a 70-30 fixed-variable pricing model. 70% of the monthly fee is fixed, covering strategy, creative, landing page, compliance, and reporting. 30% is tied to a 12-month qualified lead target on a sliding-scale slab structure, so incentives align with real pipeline outcomes rather than vanity metrics.

• Foundation, Rs 49,999/month. Single clinic, one campaign track, standard compliance stack
• Growth, Rs 74,999/month. Multi-location, up to three campaign tracks, competitor intel via Prism Spy
• Scale, Rs 99,999/month. Hospital or chain, full-funnel Meta and Instagram, dedicated compliance lead

For pharma or hospital groups needing brand campaigns with 5 lakh plus monthly spends, the same 70-30 model extends up to bespoke retainers with dedicated media and creative pods.

FAQs

Are before-and-after photos ever allowed on Meta Ads in India?

Very rarely, and only for narrow categories with tight disclaimer language. Meta's global policy discourages before/after imagery for cosmetic and weight-loss ads because the format implies guaranteed outcomes. For Indian aesthetic clinics, the safer default is process imagery, doctor-on-camera Reels, and treatment room walkthroughs. Not transformation shots.

Can Indian doctors run Meta Ads under their personal name?

Yes, subject to NMC Professional Conduct Regulations. Doctors can share qualifications, specialty focus, clinic details, educational content, and appointment availability. They cannot use superlatives, patient testimonials, comparative claims, or content that reads as soliciting patients from other practitioners.

Does Meta look at the landing page when reviewing a healthcare ad?

Yes, aggressively. Meta's review classifier crawls the destination URL as part of ad review. A landing page that promises a guaranteed cure or lacks a DPDP-aligned privacy policy will disapprove the ad even when the creative is clean. Landing page compliance is upstream of creative work.

How long does it take to recover an Indian healthcare Meta ad account after restriction?

Typically 4-8 weeks with a structured appeal, guideline-level creative fix, and landing page overhaul. Account-level restrictions ("account restricted from advertising") are harder to reverse than ad-level rejections. Prevention through compliant briefs costs a fraction of recovery.

What is the average CPL for Indian healthcare Meta Ads?

ICG benchmarks across 300+ Indian healthcare clients show dental at Rs 90-220 per qualified lead, aesthetic at Rs 180-450, IVF at Rs 350-900, and general multispecialty at Rs 60-180. Ranges vary by city, specialty, and creative quality. Compliant creative tends to sit at the lower end because Meta rewards durability with lower CPMs.

Are Meta Ads better than Google Ads for Indian healthcare acquisition?

They serve different jobs. Google Ads captures existing demand (someone already searching "IVF clinic in Delhi"), while Meta Ads creates and nurtures demand (someone scrolling who becomes aware of your fertility programme). Most Indian clinics that scale past Rs 5 lakh in monthly ad spend use both, with Meta typically at 40-60% of the mix for aesthetic, dental, and elective categories.

Does Meta share Indian healthcare ad review data with regulators?

Meta publishes an Ad Library that shows all ads, including healthcare ones, in India. Regulators and journalists routinely use it. If your Meta Ads make claims that violate NMC or the Drugs and Magic Remedies Act, that is public record. Assume every ad you run is discoverable and design it to be defensible from day one.